Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDRO-PROTECT: Hydrochlorothiazide in ADPKD
NCT05373264Phase 3Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2024
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of hydrochlorothiazide in autosomal dominant polycystic kidney disease (ADPKD), sponsored by University Medical Center Groningen. Started Jul 2024; status: recruiting.
02
Drugs
hydrochlorothiazide
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT05373264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05373264.